Effectiveness of a clinical pathway for pediatric complex appendicitis based on antibiotic stewardship principles

J Pediatr Surg. 2020 Jun;55(6):1026-1031. doi: 10.1016/j.jpedsurg.2020.02.045. Epub 2020 Mar 3.

Abstract

Purpose: Outcomes and resource utilization were evaluated after implementing a novel complex appendicitis (CA) pathway limiting postoperative antibiotics based on clinical parameters.

Methods: Children with intraoperative CA (gangrenous, perforated, or abscess) were treated with intravenous antibiotics postoperatively until clinical criteria were met, without utilizing CBC or oral antibiotics at discharge. An interrupted time series (pre-intervention, transition, post-intervention) was used to assess outcomes. Hospital length of stay (LOS) was analyzed using segmented regression. Intra-abdominal abscess and readmission rates were analyzed using non-inferiority and multivariate logistic regression.

Results: Five hundred ten children were included with a median age of 10 [IQR7-12] years. There were no differences in postoperative LOS (slope - 0.008; p = 0.855), intra-abdominal abscess rate (5% vs. 8%; p = 0.135), or readmission rate (12% vs. 8%; p = 0.113) across time periods which remained true when adjusting for age, gender, and intraabdominal disease severity. Post-intervention outcomes were not inferior to pre-intervention, abscess rate (p = 0.002), or readmission rate (p < 0.001). Intraoperative findings of perforation (OR9.0; 95% CI1-71; p = 0.044) and perforation with abscess (OR18.2; 95% CI2-36; p = 0.005) were associated with a greater likelihood of postoperative abscess compared to gangrenous appendicitis.

Conclusion: A CA protocol based on clinical parameters is safe and effective, resulting in similar intra-abdominal abscess and readmission rates compared to more resource-intense regimens.

Level of evidence: III TYPE OF RESEARCH: Interrupted Time Series.

Keywords: Abscess; Antibiotics; Complex appendicitis; Interrupted time series; Perforation.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antimicrobial Stewardship
  • Appendicitis* / drug therapy
  • Appendicitis* / epidemiology
  • Appendicitis* / surgery
  • Child
  • Critical Pathways*
  • Humans
  • Interrupted Time Series Analysis
  • Length of Stay / statistics & numerical data
  • Patient Readmission / statistics & numerical data

Substances

  • Anti-Bacterial Agents